Like a butterfly, immune protein 'flutters' in search of viruses, says Rutgers scientists

October 01, 2018

Researchers at Rutgers Robert Wood Johnson Medical School have identified an important step in the process that allows our bodies to fight viruses. Their work also explains how mutations that derail this process cause autoimmune disorders. This research, published Thursday in Molecular Cell, provides the framework to develop new treatments for viral infections.

For a virus to spread and cause an infection, it replicates itself inside of a host cell, the process of which generates viral nucleic acids such as DNA and RNA. However, our immune system has elaborate mechanisms in place to defend against both common viruses, such as influenza, and emerging viruses. The Rutgers team studied the process in which an immune receptor called RIG-I, which was discovered more than a decade ago to be a key player in the battle against RNA viruses, patrols the body in search of viral RNAs. Once the immune receptor discovers a viral RNA, it ends its search and activates the cell's antiviral response.

The study's author, Swapnil C. Devarkar, PhD, likened the process to a butterfly, "The continuous cycle of association and dissociation of RIG-I with RNAs is reminiscent of a butterfly. As a butterfly is constantly fluttering to and from anything that resembles a flower, similarly RIG-I is constantly sampling RNAs in the cell in search of a viral RNA." Dr. Devarkar is a post-doctoral fellow in the laboratory of Smita Patel, PhD, professor of biochemistry and molecular biology at the medical school.

When RIG-I discovers a viral RNA, not only does the fluttering stop, but it also signals for multiple molecules of RIG-I to gather on the viral RNA, activating the cell's antiviral response. The study has identified this as a critical step because it can only occur in the presence of viral RNAs.

In addition to this finding, the research team learned that RIG-I mutations previously linked with the autoimmune disorder Singleton-Merton syndrome cause defects in the process that normally allows RIG-I to flutter away, or disassociate, from RNAs that do not contain viral signatures. When this occurs, according to the study, mutated versions of RIG-I become trapped in stable and long-lived complexes with cellular RNAs that eventually trigger abnormal immune responses.

According to Dr. Devarkar, given the importance of RIG-I in viral infections, autoimmune diseases, and cancer immunotherapy, the findings presented in this study can be used to leverage RIG-I in antiviral and cancer therapies.
-end-
The work was a team effort between Dr. Patel's laboratory in the Department of Biochemistry and Molecular Biology at Robert Wood Johnson Medical School and Joseph Marcotrigiano, PhD, from the Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. Dr. Devarkar was assisted by graduate student Brandon Schweibenz and Chen Wang, PhD. The research was supported by NIH grants GM111959 to Dr. Patel and Dr. Marcotrigiano, and GM118086 to Dr. Patel; and the Intramural Research Program of NIAID and NIH to Dr. Wang and Dr. Marcotrigiano.

Rutgers University

Related RNA Articles from Brightsurf:

A new RNA catalyst from the lab
On the track of evolution: a catalytically active RNA molecule that specifically attaches methyl groups to other RNAs - a research group from the University of Würzburg reports on this new discovery in Nature.

Small RNA as a central player in infections
The most important pathogenicity factors of the gastric pathogen Helicobacter pylori are centrally regulated by a small RNA molecule, NikS.

RNA as a future cure for hereditary diseases
ETH Zurich scientists have developed an RNA molecule that can be used in bone marrow cells to correct genetic errors that affect protein production.

Bringing RNA into genomics
By studying RNA-binding proteins, a research consortium known as ENCODE (Encyclopedia of DNA Elements) has identified genomic sites that appear to code for RNA molecules that influence gene expression.

RNA key in helping stem cells know what to become
If every cell has the same genetic blueprint, why does an eye cell look and act so differently than a brain cell or skin cell?

RNA structures by the thousands
Researchers from Bochum and Münster have developed a new method to determine the structures of all RNA molecules in a bacterial cell at once.

New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus
Researchers in the lab of Neville Sanjana, PhD, at the New York Genome Center and New York University have developed a new kind of CRISPR screen technology to target RNA.

Discovery of entirely new class of RNA caps in bacteria
The group of Dr. Hana Cahová of the Institute of Organic Chemistry and Biochemistry of the CAS, in collaboration with scientists from the Institute of Microbiology of the CAS, has discovered an entirely new class of dinucleoside polyphosphate 5'RNA caps in bacteria and described the function of alarmones and their mechanism of function.

New RNA mapping technique shows how RNA interacts with chromatin in the genome
A group led by scientists from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed a new method, RADICL-seq, which allows scientists to better understand how RNA interacts with the genome through chromatin--the structure in which the genome is organized.

Characterising RNA alterations in cancer
The largest and most comprehensive catalogue of cancer-specific RNA alterations reveals new insights into the cancer genome.

Read More: RNA News and RNA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.